MX2010004613A - Composicion topica. - Google Patents

Composicion topica.

Info

Publication number
MX2010004613A
MX2010004613A MX2010004613A MX2010004613A MX2010004613A MX 2010004613 A MX2010004613 A MX 2010004613A MX 2010004613 A MX2010004613 A MX 2010004613A MX 2010004613 A MX2010004613 A MX 2010004613A MX 2010004613 A MX2010004613 A MX 2010004613A
Authority
MX
Mexico
Prior art keywords
topical composition
irritation
gels
compositions
active
Prior art date
Application number
MX2010004613A
Other languages
English (en)
Inventor
Isabelle Rault
Fabienne Caillet-Bois
Michel Steiger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39156258&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010004613(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2010004613A publication Critical patent/MX2010004613A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a composiciones farmacéuticas tópicas beneficiosas que comprenden la sal de dietilamonio de diclofenaco en cantidades excepcionalmente altas. Dichas composiciones representan emulsiones-geles opacas con propiedades únicas tales como alta penetración en la piel, ninguna irritación, alta estabilidad, disolución completa del principio activo y alto alivio del dolor.
MX2010004613A 2007-10-30 2008-10-27 Composicion topica. MX2010004613A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07119599A EP2055298A1 (en) 2007-10-30 2007-10-30 Topical composition
PCT/EP2008/064533 WO2009056522A1 (en) 2007-10-30 2008-10-27 Topical composition

Publications (1)

Publication Number Publication Date
MX2010004613A true MX2010004613A (es) 2010-05-20

Family

ID=39156258

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004613A MX2010004613A (es) 2007-10-30 2008-10-27 Composicion topica.

Country Status (19)

Country Link
US (1) US20100286268A1 (es)
EP (2) EP2055298A1 (es)
JP (1) JP5616228B2 (es)
KR (1) KR101531729B1 (es)
CN (2) CN104095806A (es)
AU (1) AU2008317737B2 (es)
BR (1) BRPI0819152B8 (es)
CA (1) CA2701703A1 (es)
ES (1) ES2633919T3 (es)
IL (1) IL204658A (es)
MX (1) MX2010004613A (es)
NZ (1) NZ584179A (es)
PE (1) PE20090910A1 (es)
PL (1) PL2214642T3 (es)
PT (1) PT2214642T (es)
RU (1) RU2497516C2 (es)
TW (1) TWI527597B (es)
WO (1) WO2009056522A1 (es)
ZA (1) ZA201002072B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010116382A2 (en) * 2009-04-08 2010-10-14 Cadila Healthcare Limited Stable pharmaceutical compositions of diclofenac
US20130197092A1 (en) * 2009-12-07 2013-08-01 Ketan R. Patel Novel Non-Aqueous Topical Solution of Diclofenac and Process for Preparing the Same
GB0921686D0 (en) * 2009-12-11 2010-01-27 Reckitt Benckiser Healthcare I Topical formulation
JP6131523B2 (ja) * 2011-03-25 2017-05-24 大正製薬株式会社 ロキソプロフェン含有外用剤
CN102525886B (zh) * 2012-01-13 2013-03-13 湖北科益药业股份有限公司 双氯芬酸二乙胺乳胶剂及其制备方法
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
US9999590B2 (en) * 2012-07-12 2018-06-19 Ferring B.V. Diclofenac formulations
FR3001544B1 (fr) 2013-01-31 2015-02-27 Commissariat Energie Atomique Procede de reglage de la position relative d'un analyte par rapport a un faisceau lumineux
JP6449554B2 (ja) * 2014-03-30 2019-01-09 小林製薬株式会社 外用医薬組成物
CN106604717B (zh) * 2014-09-10 2020-09-11 Gsk消费者健康有限公司 局部用双氯芬酸钠组合物
AU2018231842B2 (en) * 2017-03-07 2024-03-21 LYOTROPIC DELIVERY SYSTEMS Ltd Topical delivery systems for active compounds
BE1026073B1 (nl) * 2018-03-05 2019-10-07 Purna Pharmaceuticals Nv Verbeterde werkwijze voor het maken van een farmaceutische emulsie
CN112739325A (zh) * 2018-06-29 2021-04-30 株式会社日本触媒 油包凝胶型乳剂和透皮吸收剂
EP4054549A4 (en) * 2019-11-06 2023-12-06 Smartech Topical, Inc. TOPICAL FORMULATIONS OF CYCLO-OXYGENASE INHIBITORS AND THEIR USE
CN112263542B (zh) * 2020-10-19 2023-09-01 澳美制药厂有限公司 ***纳米乳凝胶组合物及其制备方法
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
CH655656B (es) * 1982-10-07 1986-05-15
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
WO1996004902A1 (fr) * 1994-08-09 1996-02-22 Tsumura & Co. Composition pour preparation a usage externe
JP2548686B2 (ja) * 1995-04-06 1996-10-30 エスエス製薬株式会社 外用薬剤組成物
JP3802105B2 (ja) 1995-06-27 2006-07-26 久光メディカル株式会社 ジクロフェナクナトリウム含有乳化外用剤
KR19990082208A (ko) * 1996-02-07 1999-11-25 오이시 고지 디클로페낙 나트륨의 투명 수용액 및 이를 이용한 의약 조성물
AU2953497A (en) 1996-05-13 1997-12-05 Novartis Consumer Health S.A. Topical composition
JP4275751B2 (ja) * 1996-12-27 2009-06-10 久光製薬株式会社 外用組成物
CZ290752B6 (cs) 1997-03-21 2002-10-16 Chemopharma-Trade, S.R.O. Emulgelový přípravek s protizánětlivým, analgetickým nebo protirevmatickým účinkem a způsob jeho výroby
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
US6635674B1 (en) * 1998-11-06 2003-10-21 Bristol-Myers Squibb Co. Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
CA2366852A1 (en) 1999-03-01 2000-09-08 Alejandro Fabio Scasso Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix
US6235314B1 (en) 2000-08-08 2001-05-22 Sarfaraz K. Niazi Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
TWI290464B (en) * 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
PE20040321A1 (es) 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
AR036755A1 (es) * 2002-10-07 2004-09-29 Thalas Group Inc Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
JP4866546B2 (ja) * 2004-12-10 2012-02-01 久光製薬株式会社 ジクロフェナク含有乳剤性軟膏剤

Also Published As

Publication number Publication date
ES2633919T3 (es) 2017-09-26
CN104095806A (zh) 2014-10-15
EP2214642A1 (en) 2010-08-11
WO2009056522A1 (en) 2009-05-07
EP2055298A1 (en) 2009-05-06
RU2010121989A (ru) 2011-12-10
PL2214642T3 (pl) 2017-10-31
PT2214642T (pt) 2017-07-27
TW200934530A (en) 2009-08-16
CN101820860A (zh) 2010-09-01
CA2701703A1 (en) 2009-05-07
KR101531729B1 (ko) 2015-06-25
IL204658A0 (en) 2010-11-30
IL204658A (en) 2015-10-29
JP5616228B2 (ja) 2014-10-29
EP2214642B1 (en) 2017-05-03
BRPI0819152B8 (pt) 2021-05-25
US20100286268A1 (en) 2010-11-11
KR20100083799A (ko) 2010-07-22
RU2497516C2 (ru) 2013-11-10
AU2008317737A1 (en) 2009-05-07
BRPI0819152B1 (pt) 2019-02-05
ZA201002072B (en) 2011-05-25
TWI527597B (zh) 2016-04-01
AU2008317737B2 (en) 2014-06-05
NZ584179A (en) 2012-05-25
PE20090910A1 (es) 2009-07-08
JP2011500863A (ja) 2011-01-06

Similar Documents

Publication Publication Date Title
MX2010004613A (es) Composicion topica.
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
MX2009004038A (es) Gel de diclofenaco.
WO2010045415A3 (en) Topical nsaid compositions having sensate component
BR112014010275A2 (pt) formulações para tratamento de diabetes
MX2012007933A (es) Composiciones de dexmedetomidina transdermicas topicas y metodos para su uso.
BR112015007878A2 (pt) composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
IN2012DN02817A (es)
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
ECSP10010352A (es) Gel de quitosano para aplicaciones dermatologicas, proceso de obtencion y uso del mismo
TN2012000059A1 (en) Compositions comprising tramadol and celecoxib in the treatment of pain
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
TNSN08506A1 (en) Substituted carboxamides
MD3905G2 (ro) Remediu medicamentos cu acţiune prelungită sub formă de gel pentru tratamentul afecţiunilor parodonţiului (variante)
BRPI0914947A2 (pt) composições para o tratamento de queda de cabelo
MX2009008108A (es) Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno.
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
EA201290485A1 (ru) Производные бензамида
BRPI0602179A (pt) composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
WO2007144889A3 (en) Treatment of neurofibromatosis
MX2014013083A (es) Composicion farmaceutica inyectable de dexketoprofeno y tramadol.
BRPI0923502A2 (pt) composições de soluções oculares tópicas para fornecer concentrações eficiêntes de agente ativo no segmento posterior do olho

Legal Events

Date Code Title Description
FG Grant or registration